IL34 and cancer: In the autocrine pathway, IL-34 interacts with the M-CSF receptor on cancer cells to activate signaling pathways, stimulate the growth, and spread of cancer cells and increase their resistance to chemotherapy drugs (Figure 5) (Baghdadi et al., 2016).